Risk of weight gain associated with antipsychotic treatment: results from the Canadian National Outcomes Measurement Study in Schizophrenia.

@article{McIntyre2003RiskOW,
  title={Risk of weight gain associated with antipsychotic treatment: results from the Canadian National Outcomes Measurement Study in Schizophrenia.},
  author={Roger S. McIntyre and Kostas Trakas and Daryl Lin and Robert F Balshaw and Pieway Hwang and Kimberly Robinson and Andrew Eggleston},
  journal={Canadian journal of psychiatry. Revue canadienne de psychiatrie},
  year={2003},
  volume={48 10},
  pages={689-94}
}
BACKGROUND Antipsychotic-induced weight gain occurs in a substantial percentage of treated persons. There remains a paucity of naturalistic data that describe relative weight-gain liability with the available novel atypical antipsychotics (NAPs). This investigation describes comparative NAP-induced weight gain in a prospective naturalistic cohort of persons with schizophrenia and related psychotic disorders. METHODS The Canadian National Outcomes Measurement Study in Schizophrenia (CNOMSS) is… CONTINUE READING